Skip to content

Cardiol Therapeutics Inc.

CRDL

CIK 0001702123

← back to feed
Revenue (TTM)
78.76K
FY Dec 2025
Net Income (TTM)
−33.82M
+7.8% YoY FY Dec 2025
EPS Diluted (TTM)
−0.39
+23.5% YoY FY Dec 2025
Gross Margin
—
FY Dec 2025
Operating Margin
-43,570.7%
FY Dec 2025
Net Margin
-42,939.1%
FY Dec 2025
Free Cash Flow (TTM)
—
FY Dec 2025
Cash
21.42M
FY Dec 2025
Total Debt
—
FY Dec 2025
Shares Outstanding
100.26M sh
FY Dec 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings